Maplight Therapeutics Common Stock Technical Analysis
| MPLT Stock | 16.98 1.28 8.15% |
As of the 8th of February, MapLight Therapeutics secures the Risk Adjusted Performance of 0.0312, downside deviation of 4.13, and Mean Deviation of 4.01. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MapLight Therapeutics, as well as the relationship between them.
MapLight Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as MapLight, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MapLightMapLight Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Biotechnology market expansion? Will MapLight introduce new products? Factors like these will boost the valuation of MapLight Therapeutics. Expected growth trajectory for MapLight significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about MapLight Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MapLight Therapeutics is measured differently than its book value, which is the value of MapLight that is recorded on the company's balance sheet. Investors also form their own opinion of MapLight Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is MapLight Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because MapLight Therapeutics' market value can be influenced by many factors that don't directly affect MapLight Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that MapLight Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MapLight Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MapLight Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
MapLight Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MapLight Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MapLight Therapeutics.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in MapLight Therapeutics on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding MapLight Therapeutics Common or generate 0.0% return on investment in MapLight Therapeutics over 90 days. MapLight Therapeutics is related to or competes with ProMIS Neurosciences, Edesa Biotech, Eterna Therapeutics, Biomx, BioRestorative Therapies, Immuron, and Dogwood Therapeutics. MapLight Therapeutics is entity of United States More
MapLight Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MapLight Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MapLight Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.13 | |||
| Information Ratio | 0.0128 | |||
| Maximum Drawdown | 39.27 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 8.39 |
MapLight Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MapLight Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MapLight Therapeutics' standard deviation. In reality, there are many statistical measures that can use MapLight Therapeutics historical prices to predict the future MapLight Therapeutics' volatility.| Risk Adjusted Performance | 0.0312 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0183 | |||
| Treynor Ratio | 0.0772 |
MapLight Therapeutics February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0312 | |||
| Market Risk Adjusted Performance | 0.0872 | |||
| Mean Deviation | 4.01 | |||
| Semi Deviation | 4.0 | |||
| Downside Deviation | 4.13 | |||
| Coefficient Of Variation | 3572.02 | |||
| Standard Deviation | 5.9 | |||
| Variance | 34.85 | |||
| Information Ratio | 0.0128 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0183 | |||
| Treynor Ratio | 0.0772 | |||
| Maximum Drawdown | 39.27 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 8.39 | |||
| Downside Variance | 17.07 | |||
| Semi Variance | 16.03 | |||
| Expected Short fall | (5.25) | |||
| Skewness | 2.34 | |||
| Kurtosis | 10.73 |
MapLight Therapeutics Backtested Returns
MapLight Therapeutics appears to be somewhat reliable, given 3 months investment horizon. MapLight Therapeutics has Sharpe Ratio of 0.0538, which conveys that the firm had a 0.0538 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MapLight Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise MapLight Therapeutics' Mean Deviation of 4.01, risk adjusted performance of 0.0312, and Downside Deviation of 4.13 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MapLight Therapeutics holds a performance score of 4. The company secures a Beta (Market Risk) of 2.01, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MapLight Therapeutics will likely underperform. Please check MapLight Therapeutics' potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether MapLight Therapeutics' current price movements will revert.
Auto-correlation | 0.00 |
No correlation between past and present
MapLight Therapeutics Common has no correlation between past and present. Overlapping area represents the amount of predictability between MapLight Therapeutics time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MapLight Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current MapLight Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.7 |
MapLight Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
MapLight Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of MapLight Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About MapLight Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of MapLight Therapeutics Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of MapLight Therapeutics Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on MapLight Therapeutics price pattern first instead of the macroeconomic environment surrounding MapLight Therapeutics. By analyzing MapLight Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of MapLight Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to MapLight Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | PB Ratio | 10.66 | 6.6 | 7.59 | 7.21 | Capex To Depreciation | 0.83 | 1.1 | 1.26 | 1.19 |
MapLight Therapeutics February 8, 2026 Technical Indicators
Most technical analysis of MapLight help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for MapLight from various momentum indicators to cycle indicators. When you analyze MapLight charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0312 | |||
| Market Risk Adjusted Performance | 0.0872 | |||
| Mean Deviation | 4.01 | |||
| Semi Deviation | 4.0 | |||
| Downside Deviation | 4.13 | |||
| Coefficient Of Variation | 3572.02 | |||
| Standard Deviation | 5.9 | |||
| Variance | 34.85 | |||
| Information Ratio | 0.0128 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0183 | |||
| Treynor Ratio | 0.0772 | |||
| Maximum Drawdown | 39.27 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 8.39 | |||
| Downside Variance | 17.07 | |||
| Semi Variance | 16.03 | |||
| Expected Short fall | (5.25) | |||
| Skewness | 2.34 | |||
| Kurtosis | 10.73 |
MapLight Therapeutics February 8, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as MapLight stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | 1.11 | ||
| Rate Of Daily Change | 1.08 | ||
| Day Median Price | 16.62 | ||
| Day Typical Price | 16.74 | ||
| Price Action Indicator | 1.01 | ||
| Market Facilitation Index | 1.15 |
Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics' price analysis, check to measure MapLight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics is operating at the current time. Most of MapLight Therapeutics' value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics' price. Additionally, you may evaluate how the addition of MapLight Therapeutics to your portfolios can decrease your overall portfolio volatility.